Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
On March 24, 2009, Pfizer Inc. stopped late stage Geodon pediatric clinical trials in schizophrenia (A1281134 - placebo controlled; A1281135 - open label). As recommended by the DSMB, these studies were stopped due to lack of efficacy. No safety concerns were identified.
Age
13–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participation in double-blind treatment study A1281134, meeting specific criteria of duration and safety
You may not be if
Imminent risk of suicide or homicide, as judged by the site investigator
Serious adverse event related to study medication in study A1281134
Significant prolongation of QT interval in study A1281134
Clareo Health | Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
